Beginning of October 2022, Lebanon witnessed a Cholera outbreak that started in rural areas in the North of Lebanon and spread to most regions nationwide reaching a total number of 368 confirmed laboratory cases on October 27, 2022, as reported by the Epidemiological Surveillance Unit of the Lebanese Ministry of Health. The destitute and those living in poor infrastructure once again are at the biggest disadvantage, with inadequate hygiene and sanitation, poor water treatment, and unsafe drinking water.

Responding to the emergency of the Cholera outbreak in Lebanon at the American University of Beirut Faculty of Medicine is the World Health Organization Collaborating Center for Reference and Research on Bacterial Pathogens (WHO-CC) at the Department of Experimental Pathology, Immunology, and Microbiology (EPIM) and the Center for Infectious Diseases Research (CIDR). Upon the request of the World Health Organization (WHO) and the Lebanese Ministry of Public Health (MoPH), the WHO-CC is exclusively engaged in laboratory testing of Vibrio cholerae, at the phenotypic as well as the genotypic levels, for the purpose of a nationwide genomic surveillance of the etiology of Cholera outbreak in Lebanon.

“The nationwide surveillance of Cholera is essential for a timely public health response and the implementation of control measures by the official authorities to halt the spread of the etiological agent of Cholera,” said Dr. Ghassan Matar. “It will be done through the deciphering of the identity and source of the circulating strain using state of the art technology such as Next Generation Sequencing (NGS).”

Professor Ghassan Matar, who is leading this effort, is chairperson of the Department of EPIM, associate director and laboratory director of the university’s CIDR, and director of the WHO Collaborating Center. Technical lead in this endeavor is Dr. Antoine Abou Fayad, assistant professor in the Department of EPIM. The American University of Beirut Faculty of Medicine WHO-CC is leading regionally and globally in the surveillance on Cholera and other communicable diseases as Dr. Matar serves as a member of the Global Task Force of Cholera Control.

“Through highlighting the specific genotypic characteristics of the circulating strain of V. cholerae, we can track the source of this strain and the MoPH can link this information to epidemiological data and implement proper measures to control the spread of the organism,” said Dr. Matar.

By testing clinical specimens (stool samples) and environmental samples (water and sewage) and vegetables, the American University of Beirut team was able to identify a single strain of Vibrio cholerae circulating in Lebanon. “Our findings have shown that the strain was found to belong to Serotype O1 EL TOR OGAWA, Sequence Type (ST) ST 69, which is resistant to a number of antibiotics. Phylogenetically, the Vibrio cholerae strain that is spreading nationwide in Lebanon, is similar to that of Syria and those from other countries” Said Dr. Matar. The emergency response is still ongoing.

Cholera is an acute diarrheal infection caused by the bacterium Vibrio cholerae. The infection is often mild, moderate or without symptoms, yet can sometimes be severe causing profuse watery diarrhea, vomiting with other symptoms and can be life-threatening. It is transmitted and spread in settings due to inadequate hygiene, poor sanitation, unsafe drinking water and insufficient sewage water treatment. People under these conditions are at the highest risk for cholera. Dr. Matar recommends that people adopt preventive measures related to hygiene, safe drinking water from sealed bottles of trusted sources, and using disinfectants to wash fruits and vegetables.

The American University of Beirut is keen building partnerships between its Faculty of Medicine and international organizations to raise awareness on disease outbreaks and on providing necessary precautions early on. ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​The Faculty of Medicine at the American University of Beirut is the leading internationally accredited medical education and research institution in Lebanon and the Middle East known for delivering educational and training programs in medicine and biomedical research responsive to the globally evolving needs in academic medicine and patient care. ​

-Ends-

For more information please contact:
Simon Kachar, PhD
Interim Director of the Office of Communications
Director of News and Media Relations
sk158@aub.edu.lb

About AUB

Founded in 1866, the American University of Beirut bases its educational philosophy, standards, and practices on the American liberal arts model of higher education. A teaching-centered research university, AUB has more than 800 full-time faculty members and a student body of over 8000 students. AUB currently offers more than 120 programs leading to bachelor’s, master’s, MD, and PhD degrees. It provides medical education and training to students from throughout the region at its Medical Center that includes a full-service 365-bed hospital.